69783-31-9 Usage
Uses
Used in Pharmaceutical Industry:
3,4-Dimethoxy-benzamidine is used as a pharmaceutical intermediate for the synthesis of various organic compounds and medications. Its potent and selective inhibition of factor Xa makes it a key component in the development of anticoagulant drugs, which are essential for the prevention and treatment of thrombotic disorders.
Used in Research and Development:
3,4-Dimethoxy-benzamidine is used as a research tool in the study of blood coagulation and the development of treatments for thrombotic disorders. Its ability to selectively inhibit factor Xa allows researchers to investigate the underlying mechanisms of blood clotting and explore potential therapeutic interventions for cardiovascular and thrombotic diseases.
Used in Cardiovascular and Thrombotic Disease Treatments:
3,4-Dimethoxy-benzamidine is under investigation for its therapeutic effects in various diseases related to blood clotting and inflammation. Its potential applications in the development of anticoagulant medications make it a promising candidate for the treatment of conditions such as deep vein thrombosis, pulmonary embolism, and stroke, where blood clotting plays a significant role in disease progression.
Check Digit Verification of cas no
The CAS Registry Mumber 69783-31-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,7,8 and 3 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 69783-31:
(7*6)+(6*9)+(5*7)+(4*8)+(3*3)+(2*3)+(1*1)=179
179 % 10 = 9
So 69783-31-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2O2/c1-12-7-4-3-6(9(10)11)5-8(7)13-2/h3-5H,1-2H3,(H3,10,11)
69783-31-9Relevant academic research and scientific papers
Pyridine and pyrimidine derivatives
-
, (2008/06/13)
The present invention provides compounds of formula (I) wherein R1, R2, R3, R4 and X are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment
2-Phenyl-4-(aminomethyl)imidazoles as Potential Antipsychotic Agents. Synthesis and Dopamine D2 Receptor Binding
Thurkauf, Andrew,Hutchison, Alan,Peterson, John,Cornfield, Linda,Meade, Robin,et al.
, p. 2251 - 2255 (2007/10/02)
A series of 2-phenyl-4-(aminomethyl)imidazoles were designed as conformationally restricted analogs of the dopamine D2 selective benzamide antipsychotics.The title compounds were synthesized and tested for blockade of YM-09151 binding in cloned African green monkey dopamine D2 receptor preparations.The binding affinity data thus obtained were compared against that of the benzamides and a previously described series of 2-phenyl-5-(aminomethyl)pyrroles.
